Investigative Ophthalmology & Visual Science, Vol 31, 419-428, Copyright © 1990 by Association for Research in Vision and Ophthalmology

ARTICLES AND REPORTS

Altered antigenicity of keratan sulfate proteoglycan in selected corneal diseases

JL Funderburgh, ML Funderburgh, MM Rodrigues, JH Krachmer and GW Conrad
Division of Biology, Kansas State University, Manhattan.

Monoclonal antibody against keratan sulfate (KS) was used for immunofluorescent staining of sections of human corneas from 8 normal eyes, 19 with keratoconus, 4 with pellucid marginal degeneration, 5 with primary macular corneal dystrophy, and 1 with recurrent macular corneal dystrophy. The anti-KS monoclonal antibody did not stain the corneas with primary macular corneal dystrophy, but stained all other corneas to varying degrees. Staining intensity was weaker than normal in most keratoconus and pellucid marginal degeneration corneas, and was very weak in a case of macular corneal dystrophy that had recurred in a transplanted normal cornea. In several corneas with keratoconus, normal staining was seen at the periphery, and staining intensity decreased in the thinned central portion of the stroma. The decreased KS staining was not localized in stromal scar tissue found in the keratoconus and pellucid marginal degeneration corneas. Quantitation of relative staining intensity found keratoconus and pellucid marginal degeneration corneas to be 49% and 40% as intensely stained, respectively, as normal corneas, a statistically significant decrease (P less than 0.01). Distribution of staining intensities of the keratoconus corneas demonstrated a single modality. These results are in agreement with findings of previous biochemical studies, which show reduction of highly sulfated keratan sulfate epitopes in corneas from keratoconus and pellucid marginal degeneration, and absence of sulfated keratan sulfate epitopes in macular corneal dystrophy.

This article has been cited by other articles:

				S. Akhtar, B. C. Kerr, A. J. Hayes, C. E. Hughes, K. M. Meek, and B. Caterson Immunochemical Localization of Keratan Sulfate Proteoglycans in Cornea, Sclera, and Limbus Using a Keratanase-Generated Neoepitope Monoclonal Antibody Invest. Ophthalmol. Vis. Sci., June 1, 2008; 49(6): 2424 - 2431. [Abstract] [Full Text] [PDF]

				K. M. Meek, S. J. Tuft, Y. Huang, P. S. Gill, S. Hayes, R. H. Newton, and A. J. Bron Changes in Collagen Orientation and Distribution in Keratoconus Corneas Invest. Ophthalmol. Vis. Sci., June 1, 2005; 46(6): 1948 - 1956. [Abstract] [Full Text] [PDF]

				J. L. Funderburgh, M. M. Mann, and M. L. Funderburgh Keratocyte Phenotype Mediates Proteoglycan Structure: A ROLE FOR FIBROBLASTS IN CORNEAL FIBROSIS J. Biol. Chem., November 14, 2003; 278(46): 45629 - 45637. [Abstract] [Full Text] [PDF]

				A. H. Plaas, L. A. West, E. J. A. Thonar, Z. A. Karcioglu, C. J. Smith, G. K. Klintworth, and V. C. Hascall Altered Fine Structures of Corneal and Skeletal Keratan Sulfate and Chondroitin/Dermatan Sulfate in Macular Corneal Dystrophy J. Biol. Chem., October 19, 2001; 276(43): 39788 - 39796. [Abstract] [Full Text] [PDF]

				N. Hasegawa, T. Torii, T. Kato, H. Miyajima, A. Furuhata, K. Nakayasu, A. Kanai, and O. Habuchi Decreased GlcNAc 6-O-Sulfotransferase Activity in the Cornea with Macular Corneal Dystrophy Invest. Ophthalmol. Vis. Sci., November 1, 2000; 41(12): 3670 - 3677. [Abstract] [Full Text]

				J. L. Funderburgh, M. L. Funderburgh, M. M. Mann, S. Prakash, and G. W. Conrad Synthesis of Corneal Keratan Sulfate Proteoglycans by Bovine Keratocytes in Vitro J. Biol. Chem., December 6, 1996; 271(49): 31431 - 31436. [Abstract] [Full Text] [PDF]